Skip to main content
OpenTrials

Clinical trial condition

Uterine Diseases

Explore clinical trials studying Uterine Diseases. Study availability and eligibility vary by location and protocol.

3,039 public trials 691 recruiting studies
Refine in advanced search Browse all conditions

Uterine Diseases trial results

Active, Not Recruiting

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

NCT05527184

Conditions
Adnexal Diseases, Cervical Cancer, Disease Attributes, +23 more
Locations
  • University of Alabama at Birmingham /ID# 269045 Birmingham, Alabama, United States
  • City of Hope National Medical Center /ID# 269036 Duarte, California, United States
  • Moores Cancer Center /ID# 269040 La Jolla, California, United States
  • University of California Los Angeles Medical Center /ID# 269037 Los Angeles, California, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

NCT04644068

Conditions
Additional Indications Below for Module 4 and 5, Adnexal Diseases, Biliary Cancer, +66 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Oklahoma City, Oklahoma, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer

NCT02397083

Conditions
Atypical Endometrial Hyperplasia, Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, +7 more
Locations
  • North Colorado Medical Center Greeley, Colorado, United States
  • McKee Medical Center Loveland, Colorado, United States
  • Queen's Medical Center Honolulu, Hawaii, United States
  • Covenant HealthCare Mackinaw Saginaw, Michigan, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer

NCT04068753

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations
  • Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Louisiana State University Health Science Center New Orleans, Louisiana, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • University of Virginia Cancer Center Charlottesville, Virginia, United States
View Trial Details
Active, Not Recruiting

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

NCT06710847

Conditions
Colon Cancer, Colonic Diseases, Colonic Neoplasms, +26 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site New York, United States
View all 22 locations
View Trial Details

Related conditions